Ropivacaine HCl monohydrate

Research use only, not for human use.

Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.(In Vivo):Epidural administration of Ropivacaine hydrochloride monohydrate effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury.Ropivacaine hydrochloride monohydrate inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC).Ropivacaine hydrochloride monohydrate prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats.Ropivacaine hydrochloride monohydrate inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs.

——

Epidural administration of Ropivacaine hydrochloride monohydrate effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury.Ropivacaine hydrochloride monohydrate inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC).Ropivacaine hydrochloride monohydrate prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats.Ropivacaine hydrochloride monohydrate inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs. Animal Model:Adult Sprague-Dawley rats (300–400g)Dosage:1 μM Administration:Infusion (added to the perfusate reservoir) Result:Attenuated pressure-dependent increases in filtration coefficient (Kf).

Ropivacaine hydrochloride monohydrate | Ropivacaine HCl | LEA-103 HCl | LEA 103

Others

Other Targets

Others

Others

Anaesthesia; Labour pain; Postoperative pain

132112-35-7

328.88

C17H29ClN2O2

>98% (HPLC)

DMSO:62 mg/mL (199.44 mM);Ethanol:<1 mg/mL;Water:46 mg/mL (147.97 mM)

O.Cl.CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C

——

(-20℃)

With Ice Pack

≥ 2 years